Hua Xie
Nanjing University of Chinese Medicine(CN)China Pharmaceutical University(CN)Hefei University of Technology(CN)Dalian Institute of Chemical Physics(CN)Chinese Academy of Sciences(CN)Shanghai Institute of Materia Medica(CN)Zhujiang Hospital(CN)Shanghai Children's Hospital(CN)University of Chinese Academy of Sciences(CN)Jiangxi Normal University(CN)Southern Medical University(CN)Nanjing University of Aeronautics and Astronautics(CN)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Cancer therapeutics and mechanisms, Urological Disorders and Treatments, Congenital gastrointestinal and neural anomalies
Most-Cited Works
- → Correction: Corrigendum: Down-regulation of miR-206 is associated with Hirschsprung disease and suppresses cell migration and proliferation in cell models(2016)202 cited
- → Circular RNA ZNF609 functions as a competitive endogenous RNA to regulate AKT3 expression by sponging miR-150-5p in Hirschsprung's disease(2016)176 cited
- → A New Class of Naphthalimide-Based Antitumor Agents That Inhibit Topoisomerase II and Induce Lysosomal Membrane Permeabilization and Apoptosis(2010)169 cited
- → Identification of metabolic vulnerabilities of receptor tyrosine kinases-driven cancer(2019)140 cited
- → Discovery of a novel third-generation EGFR inhibitor and identification of a potential combination strategy to overcome resistance(2020)140 cited
- → Effects of Qijian mixture on type 2 diabetes assessed by metabonomics, gut microbiota and network pharmacology(2018)